Researchers at Karolinska Institutet and AstraZeneca have discovered that gene expression in adipose stem cells varies ...
Incretin therapies based on GLP-1 receptor agonism aid in the loss of weight in obesity, but a relevant part of this loss (25%-40%) is attributed to loss of lean muscle mass, which raises the risk of ...
There has been growing interest in developing novel cannabinoid CB1 receptor inverse agonists to treat obesity and its ...